the following parameters improved under gallopamil therapy : the gallopamil group showed a significant reduction of the anginal frequency/week ( 10 +/- 8 down to 3 +/- 2 , p less than 0.001 ) , the nitroglycerin consumption ( 1.4 +/- 1.4 down to 0.3 +/- 0.6 , p less than 0.001 ) , the ischemic index ( from 63 +/- 24 down to 46 +/- 17 , p less than 0.01 ) , and the exercise tolerance ( 740 +/- 610 up to 1140 +/- 670 , p less than 0.01 ) .
C0002962
anginal
C0017887
nitroglycerin